Amgen (AMGN) Tops Q4 EPS by 42c
Tweet
Share
E-mail_58cbc46cd3c33.jpg)
Get Alerts AMGN Hot Sheet
Price: $437.23 --0%
EPS Growth %: +2.7%
Financial Fact:
Net income: 2.02B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +2.7%
Financial Fact:
Net income: 2.02B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q4 EPS of $3.81, $0.42 better than the analyst estimate of $3.39. Revenue for the quarter came in at $6.6 billion versus the consensus estimate of $6.58 billion.
GUIDANCE:
Amgen sees FY2021 EPS of $16.00-$17.00, versus the consensus of $17.02. Amgen sees FY2021 revenue of $25.8-26.6 billion, versus the consensus of $26.43 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- BMO lowers Amgen, BioNTech to Market Perform as risk-reward shifts
- Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
